#3026 An ultrasmall ruthenium-based nanoparticle to protect acute kidney injury and promote renal repair

作者
Zhuyun Zhang,Jiameng Li,Qinbo Yang,Shanshan Chen,Baihai Su
出处
期刊:Nephrology Dialysis Transplantation [Oxford University Press]
卷期号:40 (Supplement_3)
标识
DOI:10.1093/ndt/gfaf116.0980
摘要

Abstract Background and Aims Acute kidney injury (AKI) is common, with high morbidity and mortality. However, treatment options are limited. Many studies have shown a strong link between AKI and the development of chronic kidney disease (CKD), with AKI greatly increasing the risks of CKD and end-stage renal disease (ESRD). Recently, nanotechnology-based antioxidative therapy has emerged as a promising approach to alleviating oxidative stress caused by excessive reactive oxygen species (ROS). This study reports an ultrasmall ruthenium-based nanoparticle as a ROS scavenger to mitigate AKI and promote renal repair in C57 mice. Method The ultrasmall ruthenium-based nanoparticles, designated as Ru@TiO2, were synthesized by a facile one-pot solvothermal method. First, 10 ml of N, N'-dimethylformamide and 30 ml of isopropyl alcohol were mixed as the organic solvent. Subsequently, tetrabutyl orthotitanate and RuCl3 were added. We analyzed the morphology and chemical structure using transmission electron microscopy (TEM). We also assessed its enzyme-mimicking abilities in vitro, biocompatibility of Ru@TiO2, and the toxicity of Ru@TiO2 on HK2 cells and C57 mice. For AKI experiment, AKI was induced by intramuscular injection of 50% glycerin (8 ml/kg) into both hind thighs. Mice in the treatment group received Ru@TiO2 via intravenous injection into the tail following AKI induction. 24 hours later, the mice were sacrificed. For post-AKI experiment, AKI mice were treated with Ru@TiO2 every three days. 14 days later, the mice were sacrificed, and serum and renal tissue were collected for analysis. Results Characterizations of Ru@TiO2 nanozyme The low-magnification TEM images of Ru@TiO2 confirm the morphology of the nanoparticles, with a specific size of approximately 50 nm (Fig. 1c–d). High-resolution TEM (HR-TEM) of the surface region showed Ru clusters measuring approximately 1.7 nm (Fig. 1d). Figure 2a–g confirmed that Ru@TiO2 had excellent antioxidant property, SOD-like and CAT-like capabilities. Biocompatibility of Ru@TiO2 nanozyme As shown in Fig. 3a, the hemolysis rate of Ru@TiO2 was under 5% even at a high dose of 200 µg/mL, meeting the ASTM standard. It has negligible effect on routine blood tests, coagulation, or liver and kidney function (Fig. 2b–e), and did not alter the histopathology of major organs in normal mice (Fig. 2f). The cell counting kit-8 assay and Calcein AM/PI double stain also showed no cytotoxicity to HK2 cells (Fig. 2g–h). These results confirm the excellent biocompatibility of Ru@TiO2. Protective effect of Ru@TiO2 nanozyme in AKI mice Figure 4a shows that Ru@TiO2 reduced the serum creatinine and urea levels in glycerin-induced AKI mice. Hematoxylin and eosin (H&E) staining results showed many casts (red arrow) in the kidney tissue of AKI mice, which were significantly reduced after treatment with Ru@TiO2 (Fig. 4b). Additionally, Ru@TiO2 treatment effectively downregulated the expression of NGAL and KIM-1 proteins (Fig. 4c). Furthermore, treatment with Ru@TiO2 reduced IL-6 expression levels, indicating a reduction in kidney inflammation (Fig. 4e). We also observed that Ru@TiO2 treatment increased the activity of SOD, CAT, and GPX in renal tissue (Fig. 4f). These results suggest that Ru@TiO2 nanozymes enhance renal antioxidant capacity, protects kidney function and ameliorates kidney damage in AKI mice. After 14 days, mice in glycerin-induced AKI group exhibited weight loss, whereas mice in the Ru@TiO2 treatment group gained weight. Ru@TiO2 also reduced serum creatinine and urea levels, even below those in the control group. H&E staining revealed tubular damage in AKI mice, which was alleviated following Ru@TiO2 treatment. Additionally, Masson staining showed collagen fibers formation after severe AKI, while repeated Ru@TiO2 treatment slowed collagen buildup in the kidneys and alleviated the progression of renal fibrosis. Conclusion Our findings demonstrate that the ultrasmall Ru@TiO2 nanoparticle has excellent anti-ROS enzyme-mimicking capabilities. In AKI mice, Ru@TiO2 treatment effectively enhance renal antioxidant capacity, mitigate AKI and alleviate renal fibrosis progression.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
扶竹苏春完成签到,获得积分20
刚刚
闪闪凌文发布了新的文献求助30
2秒前
2秒前
我是谁的应助被归舟采纳,获得30
2秒前
明理秋天完成签到 ,获得积分10
2秒前
2秒前
希望天下0贩的0的应助被12345采纳,获得10
3秒前
meng完成签到,获得积分10
3秒前
lyw完成签到 ,获得积分10
3秒前
4秒前
桐桐的应助被LuckyYu采纳,获得10
4秒前
呼呼呼呼呼完成签到,获得积分10
5秒前
哈哈哈发布了新的文献求助10
5秒前
科研通AI6.3的应助被DW采纳,获得10
5秒前
逃离烦恼星完成签到,获得积分10
5秒前
6秒前
7秒前
8秒前
优雅的盼旋完成签到,获得积分10
8秒前
9秒前
FashionBoy的应助被鱼梓采纳,获得10
10秒前
深情安青的应助被dongzijia采纳,获得10
11秒前
饿饿饿饿完成签到,获得积分10
11秒前
龙哥发布了新的文献求助10
11秒前
12秒前
泷云完成签到,获得积分10
13秒前
13秒前
linn发布了新的文献求助30
13秒前
韩立斌完成签到,获得积分20
13秒前
CAOHOU的应助被REAL采纳,获得10
14秒前
潇洒紫发布了新的文献求助10
14秒前
哈哈哈发布了新的文献求助10
15秒前
15秒前
yy完成签到,获得积分10
15秒前
科研通AI6.2的应助被DW采纳,获得10
16秒前
16秒前
淼鑫完成签到,获得积分10
17秒前
香蕉觅云的应助被流光采纳,获得10
17秒前
17秒前
Akim的应助被日薪月亿采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188295
求助须知:如何正确求助?哪些是违规求助? 9576112
关于积分的说明 21845392
捐赠科研通 7786320
什么是DOI,文献DOI怎么找? 3435276
关于科研通互助平台的介绍 2559581
邀请新用户注册赠送积分活动 2482182